Global Alpha-Fetaprotein Testing Market Research Report 2024

Publication ID:

PB508248877

Publication Date:

August 8, 2024

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Alpha-Fetaprotein Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Alpha-Fetaprotein Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alpha-Fetaprotein Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Alpha-Fetaprotein Testing in Research Center is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Alpha-Fetaprotein Testing include Abbott, AdnaGen, Enzo Biochem, Epigenomics, Exact Sciences, Fujirebio, Gen-Probe, Applied Gene Technologies and Arca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alpha-Fetaprotein Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-Fetaprotein Testing.
Report Scope
The Alpha-Fetaprotein Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alpha-Fetaprotein Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha-Fetaprotein Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
AdnaGen
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Gen-Probe
Applied Gene Technologies
Arca
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Veridex
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
Nanogen Elitech
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Segment by Type
Immunoassays
Molecular Diagnostics
Chromosome Analysis
Others
Segment by Application
Research Center
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alpha-Fetaprotein Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-Fetaprotein Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunoassays
1.2.3 Molecular Diagnostics
1.2.4 Chromosome Analysis
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alpha-Fetaprotein Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha-Fetaprotein Testing Market Perspective (2019-2030)
2.2 Alpha-Fetaprotein Testing Growth Trends by Region
2.2.1 Global Alpha-Fetaprotein Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alpha-Fetaprotein Testing Historic Market Size by Region (2019-2024)
2.2.3 Alpha-Fetaprotein Testing Forecasted Market Size by Region (2025-2030)
2.3 Alpha-Fetaprotein Testing Market Dynamics
2.3.1 Alpha-Fetaprotein Testing Industry Trends
2.3.2 Alpha-Fetaprotein Testing Market Drivers
2.3.3 Alpha-Fetaprotein Testing Market Challenges
2.3.4 Alpha-Fetaprotein Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-Fetaprotein Testing Players by Revenue
3.1.1 Global Top Alpha-Fetaprotein Testing Players by Revenue (2019-2024)
3.1.2 Global Alpha-Fetaprotein Testing Revenue Market Share by Players (2019-2024)
3.2 Global Alpha-Fetaprotein Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha-Fetaprotein Testing Revenue
3.4 Global Alpha-Fetaprotein Testing Market Concentration Ratio
3.4.1 Global Alpha-Fetaprotein Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-Fetaprotein Testing Revenue in 2023
3.5 Alpha-Fetaprotein Testing Key Players Head office and Area Served
3.6 Key Players Alpha-Fetaprotein Testing Product Solution and Service
3.7 Date of Enter into Alpha-Fetaprotein Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-Fetaprotein Testing Breakdown Data by Type
4.1 Global Alpha-Fetaprotein Testing Historic Market Size by Type (2019-2024)
4.2 Global Alpha-Fetaprotein Testing Forecasted Market Size by Type (2025-2030)
5 Alpha-Fetaprotein Testing Breakdown Data by Application
5.1 Global Alpha-Fetaprotein Testing Historic Market Size by Application (2019-2024)
5.2 Global Alpha-Fetaprotein Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alpha-Fetaprotein Testing Market Size (2019-2030)
6.2 North America Alpha-Fetaprotein Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alpha-Fetaprotein Testing Market Size by Country (2019-2024)
6.4 North America Alpha-Fetaprotein Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha-Fetaprotein Testing Market Size (2019-2030)
7.2 Europe Alpha-Fetaprotein Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alpha-Fetaprotein Testing Market Size by Country (2019-2024)
7.4 Europe Alpha-Fetaprotein Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-Fetaprotein Testing Market Size (2019-2030)
8.2 Asia-Pacific Alpha-Fetaprotein Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alpha-Fetaprotein Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Alpha-Fetaprotein Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alpha-Fetaprotein Testing Market Size (2019-2030)
9.2 Latin America Alpha-Fetaprotein Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alpha-Fetaprotein Testing Market Size by Country (2019-2024)
9.4 Latin America Alpha-Fetaprotein Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-Fetaprotein Testing Market Size (2019-2030)
10.2 Middle East & Africa Alpha-Fetaprotein Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alpha-Fetaprotein Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Alpha-Fetaprotein Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Alpha-Fetaprotein Testing Introduction
11.1.4 Abbott Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 AdnaGen
11.2.1 AdnaGen Company Detail
11.2.2 AdnaGen Business Overview
11.2.3 AdnaGen Alpha-Fetaprotein Testing Introduction
11.2.4 AdnaGen Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.2.5 AdnaGen Recent Development
11.3 Enzo Biochem
11.3.1 Enzo Biochem Company Detail
11.3.2 Enzo Biochem Business Overview
11.3.3 Enzo Biochem Alpha-Fetaprotein Testing Introduction
11.3.4 Enzo Biochem Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.3.5 Enzo Biochem Recent Development
11.4 Epigenomics
11.4.1 Epigenomics Company Detail
11.4.2 Epigenomics Business Overview
11.4.3 Epigenomics Alpha-Fetaprotein Testing Introduction
11.4.4 Epigenomics Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.4.5 Epigenomics Recent Development
11.5 Exact Sciences
11.5.1 Exact Sciences Company Detail
11.5.2 Exact Sciences Business Overview
11.5.3 Exact Sciences Alpha-Fetaprotein Testing Introduction
11.5.4 Exact Sciences Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.5.5 Exact Sciences Recent Development
11.6 Fujirebio
11.6.1 Fujirebio Company Detail
11.6.2 Fujirebio Business Overview
11.6.3 Fujirebio Alpha-Fetaprotein Testing Introduction
11.6.4 Fujirebio Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.6.5 Fujirebio Recent Development
11.7 Gen-Probe
11.7.1 Gen-Probe Company Detail
11.7.2 Gen-Probe Business Overview
11.7.3 Gen-Probe Alpha-Fetaprotein Testing Introduction
11.7.4 Gen-Probe Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.7.5 Gen-Probe Recent Development
11.8 Applied Gene Technologies
11.8.1 Applied Gene Technologies Company Detail
11.8.2 Applied Gene Technologies Business Overview
11.8.3 Applied Gene Technologies Alpha-Fetaprotein Testing Introduction
11.8.4 Applied Gene Technologies Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.8.5 Applied Gene Technologies Recent Development
11.9 Arca
11.9.1 Arca Company Detail
11.9.2 Arca Business Overview
11.9.3 Arca Alpha-Fetaprotein Testing Introduction
11.9.4 Arca Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.9.5 Arca Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Detail
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Alpha-Fetaprotein Testing Introduction
11.10.4 Takara Bio Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.10.5 Takara Bio Recent Development
11.11 Targeted Diagnostics & Therapeutics
11.11.1 Targeted Diagnostics & Therapeutics Company Detail
11.11.2 Targeted Diagnostics & Therapeutics Business Overview
11.11.3 Targeted Diagnostics & Therapeutics Alpha-Fetaprotein Testing Introduction
11.11.4 Targeted Diagnostics & Therapeutics Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.11.5 Targeted Diagnostics & Therapeutics Recent Development
11.12 Tosoh
11.12.1 Tosoh Company Detail
11.12.2 Tosoh Business Overview
11.12.3 Tosoh Alpha-Fetaprotein Testing Introduction
11.12.4 Tosoh Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.12.5 Tosoh Recent Development
11.13 Veridex
11.13.1 Veridex Company Detail
11.13.2 Veridex Business Overview
11.13.3 Veridex Alpha-Fetaprotein Testing Introduction
11.13.4 Veridex Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.13.5 Veridex Recent Development
11.14 Beckman Coulter/Danaher
11.14.1 Beckman Coulter/Danaher Company Detail
11.14.2 Beckman Coulter/Danaher Business Overview
11.14.3 Beckman Coulter/Danaher Alpha-Fetaprotein Testing Introduction
11.14.4 Beckman Coulter/Danaher Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.14.5 Beckman Coulter/Danaher Recent Development
11.15 Becton Dickinson
11.15.1 Becton Dickinson Company Detail
11.15.2 Becton Dickinson Business Overview
11.15.3 Becton Dickinson Alpha-Fetaprotein Testing Introduction
11.15.4 Becton Dickinson Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.15.5 Becton Dickinson Recent Development
11.16 Biomedical Diagnostics
11.16.1 Biomedical Diagnostics Company Detail
11.16.2 Biomedical Diagnostics Business Overview
11.16.3 Biomedical Diagnostics Alpha-Fetaprotein Testing Introduction
11.16.4 Biomedical Diagnostics Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.16.5 Biomedical Diagnostics Recent Development
11.17 Nanogen Elitech
11.17.1 Nanogen Elitech Company Detail
11.17.2 Nanogen Elitech Business Overview
11.17.3 Nanogen Elitech Alpha-Fetaprotein Testing Introduction
11.17.4 Nanogen Elitech Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.17.5 Nanogen Elitech Recent Development
11.18 OncoLab
11.18.1 OncoLab Company Detail
11.18.2 OncoLab Business Overview
11.18.3 OncoLab Alpha-Fetaprotein Testing Introduction
11.18.4 OncoLab Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.18.5 OncoLab Recent Development
11.19 Ortho-Clinical Diagnostics
11.19.1 Ortho-Clinical Diagnostics Company Detail
11.19.2 Ortho-Clinical Diagnostics Business Overview
11.19.3 Ortho-Clinical Diagnostics Alpha-Fetaprotein Testing Introduction
11.19.4 Ortho-Clinical Diagnostics Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.19.5 Ortho-Clinical Diagnostics Recent Development
11.20 Panacea Pharmaceuticals
11.20.1 Panacea Pharmaceuticals Company Detail
11.20.2 Panacea Pharmaceuticals Business Overview
11.20.3 Panacea Pharmaceuticals Alpha-Fetaprotein Testing Introduction
11.20.4 Panacea Pharmaceuticals Revenue in Alpha-Fetaprotein Testing Business (2019-2024)
11.20.5 Panacea Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott
AdnaGen
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Gen-Probe
Applied Gene Technologies
Arca
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Veridex
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
Nanogen Elitech
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂